Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Preserved β-cell function in type 1 diabetes by mesenchymal stromal cells.

Carlsson PO, Schwarcz E, Korsgren O, Le Blanc K.

Diabetes. 2015 Feb;64(2):587-92. doi: 10.2337/db14-0656. Epub 2014 Sep 9.

2.

Diabetes: MSC transplant prevents β-cell dysfunction.

Holmes D.

Nat Rev Endocrinol. 2014 Dec;10(12):701. doi: 10.1038/nrendo.2014.172. Epub 2014 Sep 30. No abstract available.

PMID:
25265979
3.

Long term effects of the implantation of Wharton's jelly-derived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus.

Hu J, Yu X, Wang Z, Wang F, Wang L, Gao H, Chen Y, Zhao W, Jia Z, Yan S, Wang Y.

Endocr J. 2013;60(3):347-57. Epub 2012 Nov 16.

4.

Effect of a single autologous cord blood infusion on beta-cell and immune function in children with new onset type 1 diabetes: a non-randomized, controlled trial.

Giannopoulou EZ, Puff R, Beyerlein A, von Luettichau I, Boerschmann H, Schatz D, Atkinson M, Haller MJ, Egger D, Burdach S, Ziegler AG.

Pediatr Diabetes. 2014 Mar;15(2):100-9. doi: 10.1111/pedi.12072. Epub 2013 Sep 19.

PMID:
24102806
5.

Multiple intravenous infusions of bone marrow mesenchymal stem cells reverse hyperglycemia in experimental type 2 diabetes rats.

Hao H, Liu J, Shen J, Zhao Y, Liu H, Hou Q, Tong C, Ti D, Dong L, Cheng Y, Mu Y, Liu J, Fu X, Han W.

Biochem Biophys Res Commun. 2013 Jul 5;436(3):418-23. doi: 10.1016/j.bbrc.2013.05.117. Epub 2013 Jun 11.

PMID:
23770360
6.

Mesenchymal stromal cells to halt the progression of type 1 diabetes?

Carlsson PO, Korsgren O, Le Blanc K.

Curr Diab Rep. 2015 Jul;15(7):46. doi: 10.1007/s11892-015-0616-3. Review.

PMID:
26003192
7.
8.

Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes.

Vija L, Farge D, Gautier JF, Vexiau P, Dumitrache C, Bourgarit A, Verrecchia F, Larghero J.

Diabetes Metab. 2009 Apr;35(2):85-93. doi: 10.1016/j.diabet.2008.10.003. Epub 2009 Feb 20. Review.

PMID:
19230736
9.

In vitro Generated Mesenchymal Stem Cells: Suitable Tools to Target Insulin Dependent Diabetes Mellitus?

Dave SD, Patel CN, Patel JV, Thakkar UG.

Curr Stem Cell Res Ther. 2017;12(4):288-299. doi: 10.2174/1574888X12666161121112553. Review.

PMID:
27903221
10.

Autologous hematopoietic stem cell transplantation modulates immunocompetent cells and improves β-cell function in Chinese patients with new onset of type 1 diabetes.

Li L, Shen S, Ouyang J, Hu Y, Hu L, Cui W, Zhang N, Zhuge YZ, Chen B, Xu J, Zhu D.

J Clin Endocrinol Metab. 2012 May;97(5):1729-36. doi: 10.1210/jc.2011-2188. Epub 2012 Mar 14.

PMID:
22419704
11.
12.

Generation of insulin-producing cells from rat mesenchymal stem cells using an aminopyrrole derivative XW4.4.

Ouyang J, Huang W, Yu W, Xiong W, Mula RV, Zou H, Yu Y.

Chem Biol Interact. 2014 Feb 5;208:1-7. doi: 10.1016/j.cbi.2013.11.007. Epub 2013 Nov 25.

PMID:
24287272
13.

Changes in circulating adiponectin, leptin, glucose and C-peptide in patients with ketosis-prone diabetes.

Gupta P, Liu Y, Lapointe M, Yotsapon T, Sarat S, Cianflone K.

Diabet Med. 2015 May;32(5):692-700. doi: 10.1111/dme.12638. Epub 2014 Dec 17.

PMID:
25407468
14.

Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes.

Greenbaum CJ, Mandrup-Poulsen T, McGee PF, Battelino T, Haastert B, Ludvigsson J, Pozzilli P, Lachin JM, Kolb H; Type 1 Diabetes Trial Net Research Group; European C-Peptide Trial Study Group.

Diabetes Care. 2008 Oct;31(10):1966-71. doi: 10.2337/dc07-2451. Epub 2008 Jul 15.

15.

Clinical and metabolic characteristics of patients with latent autoimmune diabetes in adults (LADA): absence of rapid beta-cell loss in patients with tight metabolic control.

Chaillous L, Bouhanick B, Kerlan V, Mathieu E, Lecomte P, Ducluzeau PH, Delamaire M, Sonnet E, Maugendre D, Maréchaud R, Rohmer V, Saï P, Charbonnel B.

Diabetes Metab. 2010 Feb;36(1):64-70. doi: 10.1016/j.diabet.2009.07.004. Epub 2010 Jan 8.

PMID:
20060765
16.

Mesenchymal stem cells versus mesenchymal stem cells combined with cord blood for engraftment failure after autologous hematopoietic stem cell transplantation: a pilot prospective, open-label, randomized trial.

Xiong YY, Fan Q, Huang F, Zhang Y, Wang Y, Chen XY, Fan ZP, Zhou HS, Xiao Y, Xu XJ, Dai M, Xu N, Sun J, Xiang P, Huang XJ, Liu QF.

Biol Blood Marrow Transplant. 2014 Feb;20(2):236-42. doi: 10.1016/j.bbmt.2013.11.002. Epub 2013 Nov 8.

17.

Autografting of bone marrow mesenchymal stem cells alleviates streptozotocin‑induced diabetes in miniature pigs: real-time tracing with MRI in vivo.

Tang K, Xiao X, Liu D, Shen Y, Chen Y, Wang Y, Li B, Yu F, Ma D, Yan J, Liang H, Yang D, Weng J.

Int J Mol Med. 2014 Jun;33(6):1469-76. doi: 10.3892/ijmm.2014.1729. Epub 2014 Apr 7.

18.

Effect of heat shock protein peptide DiaPep277 on beta-cell function in paediatric and adult patients with recent-onset diabetes mellitus type 1: two prospective, randomized, double-blind phase II trials.

Schloot NC, Meierhoff G, Lengyel C, Vándorfi G, Takács J, Pánczél P, Barkai L, Madácsy L, Oroszlán T, Kovács P, Sütö G, Battelino T, Hosszufalusi N, Jermendy G.

Diabetes Metab Res Rev. 2007 May;23(4):276-85.

PMID:
17103487
19.

Relevance of beta-cell function for improved glycemic control after gastric bypass surgery.

Blanco J, Jiménez A, Casamitjana R, Flores L, Lacy A, Conget I, Vidal J.

Surg Obes Relat Dis. 2014 Jan-Feb;10(1):9-13; quiz 189-90. doi: 10.1016/j.soard.2013.07.020. Epub 2013 Aug 30.

PMID:
24342036
20.

Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation.

Zhao K, Lou R, Huang F, Peng Y, Jiang Z, Huang K, Wu X, Zhang Y, Fan Z, Zhou H, Liu C, Xiao Y, Sun J, Li Y, Xiang P, Liu Q.

Biol Blood Marrow Transplant. 2015 Jan;21(1):97-104. doi: 10.1016/j.bbmt.2014.09.030. Epub 2014 Oct 6.

Supplemental Content

Support Center